| Authors: |
Pratt EC; Molecular Pharmacology Department, Memorial Sloan Kettering Cancer Center, New York, New York., Bauer D; Molecular Pharmacology Department, Memorial Sloan Kettering Cancer Center, New York, New York., Carter LM; Molecular Pharmacology Department, Memorial Sloan Kettering Cancer Center, New York, New York., Cornejo M; Molecular Pharmacology Department, Memorial Sloan Kettering Cancer Center, New York, New York., Carrasco SE; Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, The Rockefeller University, New York, New York., Kaminsky S; Molecular Pharmacology Department, Memorial Sloan Kettering Cancer Center, New York, New York., De Gregorio R; Molecular Pharmacology Department, Memorial Sloan Kettering Cancer Center, New York, New York., Loor A; Molecular Pharmacology Department, Memorial Sloan Kettering Cancer Center, New York, New York., Friedl O; Pharmacology Department, Weill Cornell Graduate School, New York, New York., Bolaender A; Eli Lilly and Company, Indianapolis, Indiana., Chao G; Eli Lilly and Company, Indianapolis, Indiana., Castanares MA; Eli Lilly and Company, Indianapolis, Indiana., Collins EC; Eli Lilly and Company, Indianapolis, Indiana., Lewis JS; Molecular Pharmacology Department, Memorial Sloan Kettering Cancer Center, New York, New York.; Pharmacology Department, Weill Cornell Graduate School, New York, New York.; Department of Radiology, Weill Cornell Medical College, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. |
